Merus Labs International Inc
Description Merus Labs International Inc., a specialty pharmaceutical company, engages in the acquisition and licensing of branded prescription pharmaceutical products in the United States, Canada, and Europe. It offers Emselex/Enablex that is used to treat various symptoms of overactive bladder in adults; Vancocin, an antibiotic used to treat diseases resulting from the infection of Clostridium Difficile; and Factive, a quinolone with five-day oral dosing for the treatment of acute bacterial exacerbation of chronic bronchitis, and mild to moderate community-acquired pneumonia. The company serves wholesalers and distributors, physicians and allied health professionals, patients and their families/caregivers, managed care organizations and group purchasing organizations, and state and federal government health agencies. Merus Labs International Inc. is headquartered in Toronto, Canada. To view the detailed information, you need to SUBSCRIBE with us. |
 |